Key points are not available for this paper at this time.
IgAN is not a benign disease, with about 50% of patients progressing to ESRD within 30 years despite treatment.
Moriyama et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: